174 related articles for article (PubMed ID: 16998318)
1. Nephrogenic adenoma: an update on an innocuous but troublesome entity.
Rahemtullah A; Oliva E
Adv Anat Pathol; 2006 Sep; 13(5):247-55. PubMed ID: 16998318
[TBL] [Abstract][Full Text] [Related]
2. Nephrogenic adenoma of the urinary tract: a review.
Alexiev BA; LeVea CM
Int J Surg Pathol; 2012 Apr; 20(2):123-31. PubMed ID: 22415059
[TBL] [Abstract][Full Text] [Related]
3. Fibromyxoid nephrogenic adenoma: a newly recognized variant mimicking mucinous adenocarcinoma.
Hansel DE; Nadasdy T; Epstein JI
Am J Surg Pathol; 2007 Aug; 31(8):1231-7. PubMed ID: 17667548
[TBL] [Abstract][Full Text] [Related]
4. S-100A1 is a reliable marker in distinguishing nephrogenic adenoma from prostatic adenocarcinoma.
Cossu-Rocca P; Contini M; Brunelli M; Festa A; Pili F; Gobbo S; Eccher A; Mura A; Massarelli G; Martignoni G
Am J Surg Pathol; 2009 Jul; 33(7):1031-6. PubMed ID: 19384190
[TBL] [Abstract][Full Text] [Related]
5. Revisiting the immunophenotype of nephrogenic adenoma.
Fromont G; Barcat L; Gaudin J; Irani J
Am J Surg Pathol; 2009 Nov; 33(11):1654-8. PubMed ID: 19730362
[TBL] [Abstract][Full Text] [Related]
6. Clear cell adenocarcinoma of the bladder and urethra: cases diffusely mimicking nephrogenic adenoma.
Herawi M; Drew PA; Pan CC; Epstein JI
Hum Pathol; 2010 Apr; 41(4):594-601. PubMed ID: 20060152
[TBL] [Abstract][Full Text] [Related]
7. Expression of PAX8 in nephrogenic adenoma and clear cell adenocarcinoma of the lower urinary tract: evidence of related histogenesis?
Tong GX; Weeden EM; Hamele-Bena D; Huan Y; Unger P; Memeo L; O'Toole K
Am J Surg Pathol; 2008 Sep; 32(9):1380-7. PubMed ID: 18670350
[TBL] [Abstract][Full Text] [Related]
8. [Nephrogenic adenoma of the urinary bladder. A lesion that can be confused with carcinoma. Report of 4 cases].
RodrÃguez-Montes CE; Alvarado-Cabrero I
Gac Med Mex; 2001; 137(1):67-72. PubMed ID: 11244829
[TBL] [Abstract][Full Text] [Related]
9. [Nephrogenic adenoma of the bladder. Morphological and immunophenotypic study with particular attention to differential diagnosis].
Isimbaldi G; Di Nuovo F; Sironi M; Catania G; Bonacina R; Privitera O; Spinelli M
Pathologica; 1999 Jun; 91(3):192-7. PubMed ID: 10536465
[TBL] [Abstract][Full Text] [Related]
10. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
[TBL] [Abstract][Full Text] [Related]
11. Histogenesis of clear cell adenocarcinoma in the urinary tract: evidence of urothelial origin.
Sung MT; Zhang S; MacLennan GT; Lopez-Beltran A; Montironi R; Wang M; Tan PH; Cheng L
Clin Cancer Res; 2008 Apr; 14(7):1947-55. PubMed ID: 18381932
[TBL] [Abstract][Full Text] [Related]
12. Divergent differentiation in urothelial carcinoma and other bladder cancer subtypes with selected mimics.
Shanks JH; Iczkowski KA
Histopathology; 2009 Jun; 54(7):885-900. PubMed ID: 19178589
[TBL] [Abstract][Full Text] [Related]
13. Nephrogenic adenoma of the urinary tract: A 6-year single center experience.
Turcan D; Acikalin MF; Yilmaz E; Canaz F; Arik D
Pathol Res Pract; 2017 Jul; 213(7):831-835. PubMed ID: 28554748
[TBL] [Abstract][Full Text] [Related]
14. PAX2: a reliable marker for nephrogenic adenoma.
Tong GX; Melamed J; Mansukhani M; Memeo L; Hernandez O; Deng FM; Chiriboga L; Waisman J
Mod Pathol; 2006 Mar; 19(3):356-63. PubMed ID: 16400326
[TBL] [Abstract][Full Text] [Related]
15. Nephrogenic adenoma.
Amin W; Parwani AV
Pathol Res Pract; 2010 Oct; 206(10):659-62. PubMed ID: 20619548
[TBL] [Abstract][Full Text] [Related]
16. Nephrogenic adenoma identified on urine cytology using PAX-2 immunostaining.
Herlitz LC; Tong GX; Hamele-Bena D; Greenebaum E
Diagn Cytopathol; 2008 Jan; 36(1):47-9. PubMed ID: 18064687
[TBL] [Abstract][Full Text] [Related]
17. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
[TBL] [Abstract][Full Text] [Related]
18. Clear cell adenocarcinoma of the urethra: a clinicopathologic analysis of 19 cases.
Oliva E; Young RH
Mod Pathol; 1996 May; 9(5):513-20. PubMed ID: 8733766
[TBL] [Abstract][Full Text] [Related]
19. Polypoid/papillary cystitis: a series of 41 cases misdiagnosed as papillary urothelial neoplasia.
Lane Z; Epstein JI
Am J Surg Pathol; 2008 May; 32(5):758-64. PubMed ID: 18379418
[TBL] [Abstract][Full Text] [Related]
20. Nephrogenic adenoma: immunohistochemical evaluation for its etiology and differentiation from prostatic adenocarcinoma.
Xiao GQ; Burstein DE; Miller LK; Unger PD
Arch Pathol Lab Med; 2006 Jun; 130(6):805-10. PubMed ID: 16740031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
